EP1150939A4 - Nephronine: serie de composes destines au traitement de maladies infectieuses et du cancer - Google Patents

Nephronine: serie de composes destines au traitement de maladies infectieuses et du cancer

Info

Publication number
EP1150939A4
EP1150939A4 EP99966796A EP99966796A EP1150939A4 EP 1150939 A4 EP1150939 A4 EP 1150939A4 EP 99966796 A EP99966796 A EP 99966796A EP 99966796 A EP99966796 A EP 99966796A EP 1150939 A4 EP1150939 A4 EP 1150939A4
Authority
EP
European Patent Office
Prior art keywords
nephronin
cancer
compounds
series
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99966796A
Other languages
German (de)
English (en)
Other versions
EP1150939A1 (fr
Inventor
Iraj Ghadiminejad
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP1150939A1 publication Critical patent/EP1150939A1/fr
Publication of EP1150939A4 publication Critical patent/EP1150939A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/02—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton
    • C07C305/04—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to acyclic carbon atoms of a carbon skeleton being acyclic and saturated
    • C07C305/08—Dialkylsulfates; Substituted dialkylsulfates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • C07C69/704—Citric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP99966796A 1998-12-21 1999-12-21 Nephronine: serie de composes destines au traitement de maladies infectieuses et du cancer Withdrawn EP1150939A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPP7849A AUPP784998A0 (en) 1998-12-21 1998-12-21 A low molecular weigh, non-proteinaceous compound that inhibits mitogen induced cytokine production
AUPP784998 1998-12-21
PCT/AU1999/001157 WO2000037421A1 (fr) 1998-12-21 1999-12-21 Nephronine: serie de composes destines au traitement de maladies infectieuses et du cancer

Publications (2)

Publication Number Publication Date
EP1150939A1 EP1150939A1 (fr) 2001-11-07
EP1150939A4 true EP1150939A4 (fr) 2003-03-26

Family

ID=3812053

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99966796A Withdrawn EP1150939A4 (fr) 1998-12-21 1999-12-21 Nephronine: serie de composes destines au traitement de maladies infectieuses et du cancer

Country Status (5)

Country Link
EP (1) EP1150939A4 (fr)
JP (1) JP2002533317A (fr)
AU (1) AUPP784998A0 (fr)
CA (1) CA2355840A1 (fr)
WO (1) WO2000037421A1 (fr)

Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE193767C (fr) * 1906-02-17
US2636887A (en) * 1948-12-31 1953-04-28 Us Agriculture Antioxidant for fats and fatty oils
US2766145A (en) * 1954-07-26 1956-10-09 Reynolds Tobacco Co R Tobacco
DE2411479A1 (de) * 1973-03-12 1974-09-19 Kao Corp Reinigungsmittelmischung
US3929887A (en) * 1970-05-18 1975-12-30 Endo Lab Alkylenepoly(aralkylamines) and the salts thereof
EP0035742A1 (fr) * 1980-03-08 1981-09-16 Biseibutsu Kagaku Kenkyukai Dérivés d'acide homocitrique oligoriboside, procédé pour leur préparation et leur utilisation dans le traitement préventif des caries dentaires
JPS5773050A (en) * 1980-10-27 1982-05-07 Musashino Kagaku Kenkyusho:Kk Organic polymer composition stabilized with acylated hydroxycarboxylic acid type compound
US4962208A (en) * 1988-05-27 1990-10-09 Globus Alfred R Method for preparing time-stable solutions of non-pyrogenic magnesium gluconocitrates
JPH04202140A (ja) * 1990-11-29 1992-07-22 Sekisui Chem Co Ltd 経皮吸収製剤
WO1994026263A2 (fr) * 1993-05-06 1994-11-24 The Wellcome Foundation Limited Utilisation d'un complexe metallique de transition pour le traitement du choc septique
WO1995005154A1 (fr) * 1993-08-13 1995-02-23 Unilever Plc Composition nettoyante
WO1996039095A1 (fr) * 1995-06-05 1996-12-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Inserts oculaires
JPH0913065A (ja) * 1995-06-26 1997-01-14 Kao Corp ディーゼルエンジン用潤滑油添加剤及び潤滑油組成物
WO1998046217A1 (fr) * 1997-04-16 1998-10-22 Yu Ruey J Complexes moleculaires et liberation progressive d'alpha-hydroxyacides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3293176A (en) * 1964-04-01 1966-12-20 Le Roy A White Method of chelating with an ethergroup-containing sequestering agent
DE3605799A1 (de) * 1986-02-22 1987-08-27 Bayer Ag Zitronensaeurederivate als emulgatoren fuer die emulsionspolymerisation
US5756825A (en) * 1992-09-08 1998-05-26 Safavy; Ahmad Hydroxamic acid-based bifunctional chelating compounds

Patent Citations (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE193767C (fr) * 1906-02-17
US2636887A (en) * 1948-12-31 1953-04-28 Us Agriculture Antioxidant for fats and fatty oils
US2766145A (en) * 1954-07-26 1956-10-09 Reynolds Tobacco Co R Tobacco
US3929887A (en) * 1970-05-18 1975-12-30 Endo Lab Alkylenepoly(aralkylamines) and the salts thereof
DE2411479A1 (de) * 1973-03-12 1974-09-19 Kao Corp Reinigungsmittelmischung
EP0035742A1 (fr) * 1980-03-08 1981-09-16 Biseibutsu Kagaku Kenkyukai Dérivés d'acide homocitrique oligoriboside, procédé pour leur préparation et leur utilisation dans le traitement préventif des caries dentaires
JPS5773050A (en) * 1980-10-27 1982-05-07 Musashino Kagaku Kenkyusho:Kk Organic polymer composition stabilized with acylated hydroxycarboxylic acid type compound
US4962208A (en) * 1988-05-27 1990-10-09 Globus Alfred R Method for preparing time-stable solutions of non-pyrogenic magnesium gluconocitrates
JPH04202140A (ja) * 1990-11-29 1992-07-22 Sekisui Chem Co Ltd 経皮吸収製剤
WO1994026263A2 (fr) * 1993-05-06 1994-11-24 The Wellcome Foundation Limited Utilisation d'un complexe metallique de transition pour le traitement du choc septique
WO1995005154A1 (fr) * 1993-08-13 1995-02-23 Unilever Plc Composition nettoyante
WO1996039095A1 (fr) * 1995-06-05 1996-12-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Inserts oculaires
JPH0913065A (ja) * 1995-06-26 1997-01-14 Kao Corp ディーゼルエンジン用潤滑油添加剤及び潤滑油組成物
WO1998046217A1 (fr) * 1997-04-16 1998-10-22 Yu Ruey J Complexes moleculaires et liberation progressive d'alpha-hydroxyacides

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002227121, retrieved from STN Database accession no. 1993:87624 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002227122, retrieved from STN Database accession no. 1982:564032 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002227123, retrieved from STN Database accession no. 1997:203712 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002227124, retrieved from STN Database accession no. 1981:17408 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002227125, retrieved from STN Database accession no. 1996:410478 *
DATABASE CAPLUS [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002227126, retrieved from STN Database accession no. 1968:452756 *
G.R. NEWKOME ET AL, J. ORG. CHEM., vol. 56, no. 25, 1991, pages 7162 - 7167, XP002227120 *
J.L. GABRIEL ET AL, J. BIOL. CHEM., vol. 259, no. 3, 1984, pages 1622 - 1628, XP000943913 *
See also references of WO0037421A1 *
Y. ABE ET AL, YUKAGAKU, vol. 29, no. 10, 1980, pages 748 - 754 *

Also Published As

Publication number Publication date
JP2002533317A (ja) 2002-10-08
CA2355840A1 (fr) 2000-06-29
AUPP784998A0 (en) 1999-01-21
EP1150939A1 (fr) 2001-11-07
WO2000037421A1 (fr) 2000-06-29

Similar Documents

Publication Publication Date Title
AP9700939A0 (en) Compounds and methods for the treatment of cancer
AU7434101A (en) Treatment of bone diseases
EP1077704A4 (fr) Therapie combinee destinee au traitement de la depression
AP9801346A0 (en) Xanthone analogs for the treatment of infectious diseases
AU7863201A (en) Treatment of hyperproliferative diseases
AU3596199A (en) Treatment of celiac disease
IL127896A0 (en) A novel treatment for preeclampsia and related diseases
AU5425098A (en) Compounds and methods to treat infectious diseases
EP1150939A4 (fr) Nephronine: serie de composes destines au traitement de maladies infectieuses et du cancer
ZA989823B (en) Treatment of phospho gypsum
IL149281A0 (en) Treatment of cancer
EP0783891A4 (fr) Remede contre les maladies osseuses
GB9819999D0 (en) Treatment of cancer
AU1405001A (en) Treatment of diseases
IL148189A0 (en) Chemically-stabilized chlorite solutions for treating cancer and other diseases
AU1931895A (en) Treatment of graft-versus-host disease
GB9408084D0 (en) Medical treatment
AU1324002A (en) Treatment of demyelinating diseases
GB0020261D0 (en) Therapeutic treatment
IL123865A0 (en) A preparation for the treatment of skin diseases
GB9710054D0 (en) Treatment of diseases
LT98209A (en) Oinment for treating skin diseases
IL145242A0 (en) Treatment of hiatial hernia
GB9919565D0 (en) Treatment of disease
AU7438201A (en) A method of treating and preventing infectious diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030211

17Q First examination report despatched

Effective date: 20040504

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060307

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 69/003 20060101AFI20130125BHEP